Hand Grasp Function After Spinal Cord Injury

August 1, 2024 updated by: Battelle Memorial Institute

Keep it Simple: A Broadly Usable, High-performance Grasp Orthotic

The objective of this study is to advance personalized, portable, and non-invasive hand-grasp neuro-orthoses that restore naturalistic grasp functions for those with tetraplegia due to spinal cord injury (SCI), designed around their needs and preferences.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Battelle has developed a novel wearable sleeve that can reanimate a paralyzed limb via Functional Electrical Stimulation (FES) that is controlled non-invasively by the user. Previous work has shown the ability of this sleeve and FES technology to significantly enhance independence and quality of life when controlled by an implanted brain-computer interface, thus now investigators plan to trial use of the high-definition FES system with simpler, non-invasive control mechanisms to expedite translation of this technology into real-world settings. Each participant will complete up to 10 research sessions (~1.5hrs each) in their residence or at an alternative location. The study location is restricted to Columbus Ohio and surrounding areas. Participants will be compensated for their time.

In Aim 1, investigators will evaluate the ability of a non-invasive, user-controlled FES system to increase functional hand use in the homes of individuals with SCI. The research team will train participants to use the FES system for different functional hand movements and activities they identify as important to them, then measure FES system effectiveness using standardized assessments.

In Aim 2, investigators will assess the viability of using the sleeve technology to non-invasively record muscle activity as the participant attempts different functional movements.

In Aim 3, human-centric design methodology and contextual inquiry interviews will be employed to understand study participants' needs and preferences for a FES assistive device. This information will determine actions to improve usability and optimize the system for unsupervised home use.

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43201
        • Battelle Memorial Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ≥ 18 years old
  • ≥ 12 months post-SCI and medically/neurologically stable
  • Cervical spinal cord injury (C1-C8); any etiology except neurodegenerative conditions
  • Unable to grasp objects independently with both hands (tetraplegia)
  • Manual muscle testing (MMT) scores ≥4/5 for elbow flexion and ≥2/5 for wrist extension
  • Willing to participate in sessions at home or able to travel to alternate site for study sessions

Exclusion Criteria:

  • Ventilator-dependent (dependent upon mechanical life support due to inability to breathe effectively)
  • Poorly controlled autonomic dysreflexia (more than one episode in 3 months prior to enrollment)
  • Moderate to severe spasticity (Modified Ashworth Scale (MAS) >1+) in the hand, wrist, or forearm
  • Received a localized injection (e.g. Botox) to hand, wrist, or forearm muscles within past 12 months
  • Currently participating in physical rehabilitation for upper extremity impairments
  • Individuals having or requiring any of the following: implanted pacemaker, life supporting/sustaining equipment, or critical non-removable implantable electronic devices such as an insulin pump or neurostimulator.
  • Presence of any other clinically significant medical comorbidity and/or neurological condition for which participation in the study may pose a safety risk and/or influence results
  • Presence of the following medical conditions: uncontrolled seizure disorder, active malignancy in the upper extremities, or open wounds/infections in the upper extremities
  • Individuals whose forearm is determined to be too small or too large to fit the electrode sleeve being investigated
  • Individuals who are pregnant or plan to get pregnant during the course of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Non-invasive FES
Wearable FES sleeve with non-invasive user controls
Wearable FES sleeve with non-invasive user controls

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of FES sleeve as a functional orthosis for activities of daily living
Time Frame: 10 weeks
Semi structured interviews will involve gaining participants opinions on the strengths and weaknesses of the system
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quadriplegia Index of Function (QIF)
Time Frame: At study completion, 10 weeks
Self-report tool assessing 37 activities of daily living with each task scored from 0 to 4 in order of increasing independence.
At study completion, 10 weeks
Change in Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) after 10 weeks
Time Frame: 10 weeks
Standardized test will assess participant's ability to perform complex grasp tasks: pouring a bottle; opening lids on two sizes of jars; inserting/turning key in lock; manipulating pegs in a pegboard; inserting four sizes of coins into slots; and screwing four sizes of nuts onto bolts
10 weeks
Psychosocial Impact of Assistive Devices Scale (PIADS)
Time Frame: At study completion, 10 weeks
Assesses user opinions of assistive devices across 26 items, describing likelihood of device adoption for regular use and psychosocial effects of use on function independence, well-being, and quality of life. Each item is scored on a 7 point Likert Scale from -3 to 3 with higher scores indicating more positive impact.
At study completion, 10 weeks
Change in Electromyography (EMG) signal metrics
Time Frame: 10 weeks
Metrics derived from noninvasively recorded electromyography activity as the user attempts functional hand movements
10 weeks
Number of serious adverse events
Time Frame: 10 weeks
Assessed by number of incidences
10 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Setup time (minutes)
Time Frame: 10 Weeks
The time it takes to physically don, connect, and calibrate system components
10 Weeks
Canadian Occupational Performance Measure (COPM)
Time Frame: Week 1, First session
A 9 item assessment to measure perceived occupational performance of self-care, productivity and leisure. COPM uses semi-structured interview questions to identify activities that the individuals wants, needs or is expected to perform.
Week 1, First session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: David A Friedenberg, PhD, Battelle

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 5, 2022

Primary Completion (Actual)

July 31, 2024

Study Completion (Actual)

July 31, 2024

Study Registration Dates

First Submitted

October 19, 2021

First Submitted That Met QC Criteria

November 10, 2021

First Posted (Actual)

November 22, 2021

Study Record Updates

Last Update Posted (Actual)

August 5, 2024

Last Update Submitted That Met QC Criteria

August 1, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on User-controlled FES system

Subscribe